Cuprina Holdings (Cayman) Limited (CUPR) vs Harvard Bioscience, Inc. (HBIO)

Cuprina Holdings (Cayman) Limited and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $36.5M against $10.6M — 3.4× the size. Across the 5 metrics below, Cuprina Holdings (Cayman) Limited leads on 5 and Harvard Bioscience, Inc. on 0.

Valuation

Metric CUPR HBIO Medical Instruments & Supplies median
P/E — n/m 34.17
P/S — 0.41 2.83
P/B n/m 4.86 2.82
Price to free cash flow — n/m 25.69
EV/EBITDA n/m 14.15 16.08
EV/Sales n/m 1.14 3.06
Earnings yield — (29.02%) (1.84%)
Free cash flow yield — (5.09%) 0.17%

Profitability

Metric CUPR HBIO Medical Instruments & Supplies median
Gross margin — 58.16% 54.62%
Operating margin — (0.28%) 1.64%
Net margin — (11.86%) 0.00%
Free cash flow margin — (2.09%) 1.61%
Return on equity — (89.95%) 0.00%
Return on assets — (13.32%) 0.00%
Return on invested capital 0.00% (0.41%) 0.00%

Growth

Metric CUPR HBIO Medical Instruments & Supplies median
Revenue growth (TTM) — (1.06%) 9.20%
EPS growth (last fiscal year) (200.00%) (357.14%) —
Revenue growth, 5-year CAGR — (3.25%) 9.48%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUPR HBIO Medical Instruments & Supplies median
Debt to equity 0.07 4.95 0.08
Current ratio 2.35 1.87 2.49
Net debt to EBITDA 0.57 4.11 0.83

Dividend

Metric CUPR HBIO Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — 0.00 0.00

Size

Metric CUPR HBIO Medical Instruments & Supplies median
Market cap 10.64m 36.51m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack